Patents by Inventor Graham P. Wright

Graham P. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED REGULATORY T CELL
    Publication number: 20250154532
    Abstract: The present invention relates to an engineered regulatory T cell (Treg) comprising a T cell receptor (TCR) which is capable of specifically binding to a myelin basic protein (MBP) peptide or variant or fragment thereof when the peptide is presented by a major histocompatibility complex (MHC) molecule. The present invention further relates to methods for providing an engineered Treg and to methods and uses of said engineered Treg and vectors and kits of vectors encoding said Treg.
    Type: Application
    Filed: January 16, 2025
    Publication date: May 15, 2025
    Inventors: Hans Stauss, Graham P. Wright, Jenny L. McGovern
  • Engineered regulatory T cell
    Patent number: 12227756
    Abstract: The present invention relates to an engineered regulatory T cell (Treg) comprising a T cell receptor (TCR) which is capable of specifically binding to a myelin basic protein (MBP) peptide or variant or fragment thereof when the peptide is presented by a major histocompatibility complex (MHC) molecule. The present invention further relates to methods for providing an engineered Treg and to methods and uses of said engineered Treg and vectors and kits of vectors encoding said Treg.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: February 18, 2025
    Assignee: UCL Business Ltd
    Inventors: Hans Stauss, Graham P. Wright, Jenny L. McGovern
  • ENGINEERED REGULATORY T CELL
    Publication number: 20210145884
    Abstract: The present invention relates to an engineered regulatory T cell (Treg) comprising a T cell receptor (TCR) which is capable of specifically binding to a myelin basic protein (MBP) peptide or variant or fragment thereof when the peptide is presented by a major histocompatibility complex (MHC) molecule. The present invention further relates to methods for providing an engineered Treg and to methods and uses of said engineered Treg and vectors and kits of vectors encoding said Treg.
    Type: Application
    Filed: April 17, 2019
    Publication date: May 20, 2021
    Inventors: Hans Stauss, Graham P. Wright, Jenny L. McGovern